Preços e notícias sobre as ações Regulus Therapeutics Inc (RGLS): Google Finanças

Página inicialRGLS • NASDAQ

Regulus Therapeutics Inc

$ 1,78

Após o fechamento:

$ 1,65

(7,30%)-0,13

Fechados: 11 de abr., 17:49:14 GMT-4 · USD · NASDAQ · Exoneração de responsabilidade

Último fechamento

$ 1,72

Variações de hoje

$ 1,63 - $ 1,84

Variações do ano

$ 0,83 - $ 2,90

Capitalização de mercado

117,91 mi USD

Volume médio

1,72 mi

Índice P/L

Rend. de dividendos

Bolsa principal

NASDAQ

Notícias sobre o mercado

Fortune

há 2 horas

Just to break even after the recent selloff, stocks will need to have the sort of rally that only happens during bull markets

.INX

1,81%

Investor's Business Daily

há 2 horas

Will Dow Jones Futures Rally On Big Trump Tariff Exemption For Apple, Techs? There's A Big Catch.

Freak sell-off of ‘safe haven’ US bonds raises fear that confidence in America is fading

Nasdaq

há 5 horas

Nasdaq Bear Market: 2 No-Brainer Stocks to Buy Right Now

AOL.com

há 6 horas

SPDR Portfolio S&P 1500 Composite Stock Market ETF: What Do You Get When You Buy "Everything"?

Is Amazon.com Inc. (NASDAQ:AMZN) the Best Tech Stock to Buy For Long-Term Investment?

Sobre

Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia

Data da fundação

set. 2007

Site

regulusrx.com

Empregados